Totus Medicines
PrivateLast Round
Series B
Dec 15, 2023
Total Funding Raised
$109M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Totus Medicines is a biotechnology company that develops precision oral medicines for previously untreatable diseases using its proprietary AI-powered OmniDEL drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Totus Medicines Comparables
Compare Totus Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Frontier Medicines | 89% | |
| Matchpoint Therapeutics | 86% | |
| Nexo Therapeutics | 85% |
Totus Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 15, 2023 | ||||
| Series A | Dec 9, 2021 |
Key People
Founding team and executive leadership
Totus Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series A, Series B |
| Camford Capital | Series A, Series B |
| Northpond Ventures | Series B, Series A |
| Social Impact Capital | Series A, Pre Seed, Seed |
| University of Minnesota | Series B |
| Northpond Ventures | Series B, Series A |
| Camford Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 113% MoM, reaching 2.3K.
- Apr 16, 2026
Presenting data on covalent IRF5 inhibitor at AAI IMMUNOLOGY2026.
Totus Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Totus Medicines's valuation, stock price, and market status.
Is Totus Medicines a public or private company?
Totus Medicines is a private company.
What is the current stock price of Totus Medicines?
Totus Medicines is a private company with no public stock price. No recent secondary market data is available.
How much is Totus Medicines worth (valuation)?
Valuation information for Totus Medicines is not publicly available.
Can I buy Totus Medicines stock?
Totus Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Totus Medicines's last funding round?
Totus Medicines's most recent funding round was Series B on December 15, 2023.
Who are the main investors in Totus Medicines?
Key investors in Totus Medicines include DCVC Bio, Northpond Ventures, Northpond Ventures, DCVC (Data Collective).
Will Totus Medicines IPO soon?
No public IPO plans have been announced for Totus Medicines.
How can I track Totus Medicines secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Totus Medicines's secondary market activity and sign up for updates.